Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

April 2013 - FRMC

Department
Oral Therapy for Chronic Weight Management - Qsymia® (phentermine and topiramate extended-release) capsules
04/22/2013
The FDA approved Qsymia® (phentermine and topiramate extended-release) capsules in July 2012 as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in people with a body mass index ≥30 kg/m2...
The FDA approved Qsymia® (phentermine and topiramate extended-release) capsules in July 2012 as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in people with a body mass index ≥30 kg/m2...
The FDA approved Qsymia®...
04/22/2013
First Report Managed Care
Department
Infliximab for Treatment-Resistant Depression
04/22/2013

Kevin L. Carter

Kevin L. Carter
About one third of depressed patients fail to respond to conventional antidepressant medication. It is believed that inflammation is a possible mechanism that contributes to this treatment resistance. A number of inflammatory biomarkers...
About one third of depressed patients fail to respond to conventional antidepressant medication. It is believed that inflammation is a possible mechanism that contributes to this treatment resistance. A number of inflammatory biomarkers...
About one third of depressed...
04/22/2013
First Report Managed Care
Cardiovascular Events and Polycythemia Vera
04/22/2013

Kevin L. Carter

Kevin L. Carter
Polycythemia vera is a rare hematologic neoplasm characterized by clonal proliferation of multipotent bone marrow progenitors, leading to abnormal production of erythroid cells and an increased red-cell mass. Acquired mutations in JAK2 (JAK2...
Polycythemia vera is a rare hematologic neoplasm characterized by clonal proliferation of multipotent bone marrow progenitors, leading to abnormal production of erythroid cells and an increased red-cell mass. Acquired mutations in JAK2 (JAK2...
Polycythemia vera is a rare...
04/22/2013
First Report Managed Care
Costs of Biologics to Treat Psoriasis
04/22/2013

Tim Casey

Tim Casey
Miami Beach—During a 10-year period, the average direct costs per patient with moderate-to-severe psoriasis who took biologics were nearly $200,000 regardless of the drug they were prescribed, while productivity losses averaged around...
Miami Beach—During a 10-year period, the average direct costs per patient with moderate-to-severe psoriasis who took biologics were nearly $200,000 regardless of the drug they were prescribed, while productivity losses averaged around...
Miami Beach—During a 10-year...
04/22/2013
First Report Managed Care
Analysis of Acitretin to Treat Psoriasis
04/22/2013

Tim Casey

Tim Casey
Miami Beach—An analysis of national survey data found that patients with psoriasis typically use acitretin in combination with other agents. However, women of childbearing potential are typically not prescribed the drug due to serious side...
Miami Beach—An analysis of national survey data found that patients with psoriasis typically use acitretin in combination with other agents. However, women of childbearing potential are typically not prescribed the drug due to serious side...
Miami Beach—An analysis of...
04/22/2013
First Report Managed Care
Patients with TTR Amyloidosis Using Pacemakers
04/22/2013

Tim Casey

Tim Casey
San Francisco—Patients with transthyretin (TTR) amyloidosis who had pacemakers were more likely to be older and male, and have greater beta-blocker use, greater left ventricular septal thickness, and higher brain natriuretic peptide levels...
San Francisco—Patients with transthyretin (TTR) amyloidosis who had pacemakers were more likely to be older and male, and have greater beta-blocker use, greater left ventricular septal thickness, and higher brain natriuretic peptide levels...
San Francisco—Patients with...
04/22/2013
First Report Managed Care
PCI versus Pharmaco-Invasive Regimen in STEMI Patients
04/22/2013

Tim Casey

Tim Casey
San Francisco—Patients with ST-elevation myocardial infarction (STEMI) treated at community hospitals or in ambulances had similar results whether they underwent percutaneous coronary intervention (PCI) or received a pharmaco-invasive...
San Francisco—Patients with ST-elevation myocardial infarction (STEMI) treated at community hospitals or in ambulances had similar results whether they underwent percutaneous coronary intervention (PCI) or received a pharmaco-invasive...
San Francisco—Patients with...
04/22/2013
First Report Managed Care
Integrated Healthcare System’s Effect on Clinical and Economic Results
04/22/2013

Tim Casey

Tim Casey
San Francisco—A retrospective cohort study found that for patients with atrial fibrillation and atrial flutter, a closed system healthcare model was associated with significantly lower costs compared with an open system model over a 12-month...
San Francisco—A retrospective cohort study found that for patients with atrial fibrillation and atrial flutter, a closed system healthcare model was associated with significantly lower costs compared with an open system model over a 12-month...
San Francisco—A retrospective...
04/22/2013
First Report Managed Care
Ranolazine for Type 2 Diabetes, Coronary Artery Disease, and Chronic Stable Angina
04/22/2013

Tim Casey

Tim Casey
San Francisco—Patients with type 2 diabetes, coronary artery disease, and chronic stable angina who took ranolazine had fewer angina episodes and fewer sublingual nitroglycerin dosages compared with a group receiving placebo, according to a...
San Francisco—Patients with type 2 diabetes, coronary artery disease, and chronic stable angina who took ranolazine had fewer angina episodes and fewer sublingual nitroglycerin dosages compared with a group receiving placebo, according to a...
San Francisco—Patients with type...
04/22/2013
First Report Managed Care
Eplerenone in STEMI Patients with No History of Heart Failure
04/22/2013

Tim Casey

Tim Casey
San Francisco—After a mean follow-up of 10.5 months, patients with acute ST-segment elevation myocardial infarction (STEMI) who, having no diagnosis of heart failure, took eplerenone in addition to standard treatment had a significant...
San Francisco—After a mean follow-up of 10.5 months, patients with acute ST-segment elevation myocardial infarction (STEMI) who, having no diagnosis of heart failure, took eplerenone in addition to standard treatment had a significant...
San Francisco—After a mean...
04/22/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Shortened Hospital Stay With Standardized Order Set
09/14/2018
Compared with usual care, care provided under an electronic health system-based standardized order set was associated with a 31% lower steroid dose and a 1.1-day shorter length of stay in the hospital, with no effect on readmission rates, a...
Compared with usual care, care provided under an electronic health system-based standardized order set was associated with a 31% lower steroid dose and a 1.1-day shorter length of stay in the hospital, with no effect on readmission rates, a...
Compared with usual care, care...
09/14/2018
First Report Managed Care
News
‘Meaningful Use’ Regs for Electronic Medical Records Finally Drop!
07/14/2010
07/14/2010
First Report Managed Care
News
Debate Over Health Plan-Driven Clinical Pathways Continues
08/15/2016

By Dean Celia

By Dean Celia
While a California bill to restrict payer-driven clinical pathways was defeated, a similar bill was recently proposed in Connecticut, further stoking the debate between whether or not payers should be allowed to have input in the development...
While a California bill to restrict payer-driven clinical pathways was defeated, a similar bill was recently proposed in Connecticut, further stoking the debate between whether or not payers should be allowed to have input in the development...
While a California bill to...
08/15/2016
First Report Managed Care
News
Carper, Coburn urge supercommittee to focus on Medicare, Medicaid waste
10/13/2011
10/13/2011
First Report Managed Care
News
Call for Inclusion of PCPs in Hospital Teams
01/28/2015
Internal medicine resaerchers from Massachusetts General Hospital have proposed a collaborative model that coordinates primary care practitioners and hospitalists.
Internal medicine resaerchers from Massachusetts General Hospital have proposed a collaborative model that coordinates primary care practitioners and hospitalists.
Internal medicine resaerchers...
01/28/2015
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

April 2013 Volume 10 Issue 4

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement